1. If a practitioner, other than a veterinarian, intends to prescribe a controlled substance listed in schedule II, III or IV for more than 30 days for the treatment of pain, the practitioner must, not later than 30 days after issuing the initial prescription, enter into a prescription medication agreement with the patient, which must be:

(a) Documented in the record of the patient; and

(b) Updated at least once every 365 days while the patient is using the controlled substance or whenever a change is made to the treatment plan established pursuant to paragraph (c) of subsection 1 of NRS 639.23911.

2. A prescription medication agreement entered into pursuant to subsection 1 must include, without limitation:

(a) The goals of the treatment of the patient;

(b) Consent of the patient to testing to monitor drug use when deemed medically necessary by the practitioner;

(c) A requirement that the patient take the controlled substance only as prescribed;

(d) A prohibition on sharing medication with any other person;

(e) A requirement that the patient inform the practitioner:

(1) Of any other controlled substances prescribed to or taken by the patient;

(2) Whether the patient drinks alcohol or uses cannabis or any other cannabinoid compound while using the controlled substance;

(3) Whether the patient has been treated for side effects or complications relating to the use of the controlled substance, including, without limitation, whether the patient has experienced an overdose; and

(4) Each state in which the patient has previously resided or had a prescription for a controlled substance filled;

(f) Authorization for the practitioner to conduct random counts of the amount of the controlled substance in the possession of the patient;

(g) The reasons the practitioner may change or discontinue treatment of the patient using the controlled substance; and

(h) Any other requirements that the practitioner may impose.

(Added to NRS by 2017, 4433)